Introduction
============

C-type lectin receptors (CLRs) are proteins that contain carbohydrate recognition domains (CRDs) and bind carbohydrate structures in a Ca^2+^-dependent manner. Ca^2+^ ions are directly involved in ligand binding, as well as in maintaining the structural integrity of the CRD that is necessary for the lectin activity \[[@bib1]\]. Depending on the amino acid sequence, the CRD has specificity for mannose, galactose or fucose structures. Moreover, interaction of these carbohydrate structures with the different CLRs is dependent on carbohydrate branching, spacing and multivalency.

CLRs are either produced as transmembrane proteins or are secreted as soluble proteins ([Table 1](#tbl1){ref-type="table"} ). They have been shown to act both as adhesion and as pathogen-recognition receptors \[[@bib2]\]. The broad selectivity of the monosaccharide-binding site and the geometrical arrangement of multiple CRDs provide a first basis for discriminating between self and non-self \[[@bib3]\]. Thus, CLRs recognize carbohydrate patterns expressed by the invading microorganisms and have a role in both innate and adaptive immunity \[[@bib4]\]. Several microorganisms have developed strategies for exploiting the CLR-mediated uptake to their benefit, and evade the host immune defenses \[[@bib5], [@bib6]\].Table 1Overview of two subfamilies of C-type lectins and their most recently identified ligands.Group[a](#tbl1fn1){ref-type="table-fn"}Molecular structureC-type lectinNewly identified pathogens \[specific ligand\]ReferencesCollectinsSolubleMBL*Neisseria meningitidis* \[nonglycosylated outer membrane opacity protein and porin\]\[[@bib14]\]SP-A*Mycobacterium avium* \[lipoarabinomannan\]\[[@bib38]\]SP-D*Mycobacterium avium* \[lipoarabinomannan\]\[[@bib38]\]*Schistosoma mansoni* \[α1-3-linked fucose\]\[[@bib13]\]All three members (MBL, SP-A and SP-D) bind free DNA and apoptotic cell-derived DNA\[[@bib42]\]  Type II receptorsType II transmembraneDC-SIGNHepatitis C virus \[E1 and E2 glycoproteins\]\[[@bib43]\]Marburg virus \[GP-glycoprotein\]\[[@bib44]\]SARS-CoV[b](#tbl1fn2){ref-type="table-fn"} \[S-glycoprotein\]\[[@bib44]\]*Helicobacter pylori* \[Lewis X/Y LPS\]\[[@bib26]\]*Aspergillus fumigatus* \[galactomannan\]\[[@bib45]\]*Mycobacterium tuberculosis* \[(man)3-ara\]\[[@bib11]\]L-SIGNHepatitis C virus \[E1 and E2 glycoproteins\]\[[@bib43]\]Marburg virus \[GP-glycoprotein\]\[[@bib44]\]SARS-CoV \[S-glycoprotein\]\[[@bib44], [@bib46]\]*Mycobacterium tuberculosis* \[(man)3-ara\]\[[@bib11]\]*Schistosoma mansoni*\[[@bib10]\]mSIGN-R1*Streptococcus pneumoniae* \[capsular polysaccharide\]\[[@bib47]\]*Mycobacterium tuberculosis* \[(man)3-ara\]\[[@bib11]\]Langerin*Mycobacterium leprae* \[nonpeptide antigen\]\[[@bib33]\][^1][^2]

In this review, we focus on the role of CLRs in the recognition of pathogens that leads either to immune protection or immune evasion. We discuss binding specificity as a consequence of differences in ligand glycosylation, the molecular and structural elements that regulate the interaction with pathogen-associated molecular patterns (PAMPs) and, finally, the increasing evidence of interactions with other immune receptor families, which adds to the complexity of CLR-mediated pathogen recognition.

Identification of new carbohydrate structures
=============================================

Recent findings reported by several investigators indicate that CLRs recognize subtle differences in the arrangement and branching of the carbohydrate residues. Despite the fact that several CLRs share a CRD and bind mannose-containing structures, different branching and spacing of these structures create unique sets of carbohydrate-recognition profiles for each receptor.

Therapeutic manipulation of carbohydrate--protein interactions requires detailed knowledge of the specific spectrum of carbohydrate structures recognized by each CLR. Oligosaccharide microarray technologies are currently being applied to facilitate a systematic and high-throughput analysis of protein--carbohydrate interactions.

A well-known example is the neoglycolipid technology that generates lipid-linked oligosaccharide arrays from glycoproteins, glycolipids, proteoglycans, polysaccharides, whole organs or chemically synthesized oligosaccharides \[[@bib7]\]. By glycan array profiling, discrimination between high- and low-affinity carbohydrate ligands for the murine CLRs specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin (SIGN)-R1, SIGN-R3 and langerin has been achieved \[[@bib8]\].

Alternative glycan arrays have also been documented. Recently, Guo *et al*. \[[@bib9]\] showed that dendritic cell (DC)-SIGN and its homolog L-SIGN have distinct ligand-binding properties. Whereas L-SIGN was only able to bind to mannose-containing ligands, DC-SIGN reacted with many more glycans, including fucose moieties on Lewis blood group antigens \[[@bib9]\]. The observation that DC-SIGN and L-SIGN differ in their carbohydrate-binding profiles was also reported by van Liempt *et al*. \[[@bib10]\]. By examining the binding of various mutants of DC-SIGN and L-SIGN to *Schistosoma mansoni* egg antigen, they showed that the difference in one single amino acid at the binding site is responsible for the fucose specificity of DC-SIGN \[[@bib10]\]. More specifically, they indicate that although L-SIGN seems unable to bind to Lewis-X, it still interacts with other fucosylated glycans such as Lewis A, -B and --Y \[[@bib10]\].

The specific carbohydrate structure recognized by DC-SIGN and its homologs L-SIGN and murine SIGN-R1 on mycobacterial mannosylated lipoarabinomannan was also identified, all receptors showing similar affinity for the mannose-cap oligosaccharide (man)3-ara ([Table 1](#tbl1){ref-type="table"}) \[[@bib11]\].

Finally, biochemical studies using mutants of DC-SIGN demonstrated that binding to the HIV envelope protein gp120 is mediated by a distinct but overlapping epitope when compared with ICAM-2 and ICAM-3, providing a rationale for specific targeting of the gp120--DC-SIGN interaction, without affecting other physiologically important ICAM-2 and ICAM-3 interactions with DC-SIGN \[[@bib12]\].

Several new carbohydrate structures have been identified for other CLRs, such as surfactant protein (SP)-D ([Table 1](#tbl1){ref-type="table"}). Despite the fact that this soluble CLR is a key component of the innate immunity in lung alveoli, limited information is available on its binding to complex carbohydrate structures. Recently, by using surface plasmon resonance spectroscopy, van de Wetering *et al*. \[[@bib13]\] identified terminal α1-3-linked fucose residues as strong ligands for SP-D. Furthermore, for the first time, SP-D was shown to bind multicellular larval stages of the parasitic worm *Schistosoma mansoni*, transiently residing in the lung, by interacting with these fucosylated glycans exposed at the cell surface \[[@bib13]\].

Novel binding targets were also identified in the interaction between the collectin mannose-binding lectin (MBL) and the bacterium *Neisseria meningitidis* ([Table 1](#tbl1){ref-type="table"}). Surprisingly, MBL was found to bind meningococci via two nonglycosylated major outer membrane proteins, opacity protein and porin, of *N. meningitidis* \[[@bib14]\]. Binding of CLRs to nonsugar targets on the surface of pathogens might further increase the complexity of pathogen--CLR interactions.

C-type lectin oligomerization: multivalent microdomains bind to microbial surfaces
==================================================================================

The capacity of CLRs to detect microorganisms depends on the density of the PAMP present on the microbial surface, as well as on the degree of oligomerization of the lectin receptor. In fact, the assembly of several CRDs in multimers points the binding sites towards a common direction, increasing the binding valency and allowing interactions with the dense carbohydrate arrays on microbial surfaces.

The collectins form trimers, which further assemble into larger oligomers, appearing as a 'bouquet of flowers' \[[@bib15]\]. Mutations that hamper the assembly of human MBL into oligomers result in a reduced capability to activate components of the complement system, thus increasing both the risk and severity of infections and leading to autoimmunity \[[@bib16]\].

Moreover, transmembrane CLRs have developed several strategies to increase their strength of binding to PAMPs. Proteomic analysis of membrane-purified DC-SIGN complexes showed that DC-SIGN exists as tetramers at the surface of immature monocyte-derived DCs, and that this assembly is required for high-affinity binding of glycoproteins such as HIV gp120 \[[@bib17]\]. Moreover, biochemical and hydrodynamic studies on truncated DC-SIGN demonstrated that the portion of the neck of each molecule adjacent to the CRD is sufficient to mediate the formation of dimers, whereas the neck regions near the amino-terminal are required to stabilize tetramers \[[@bib18]\]. In the same study, it was also shown that the CRDs are flexibly linked to the neck regions, which project CRDs from the cell surface and enable DC-SIGN to bind to various glycans on microbial surfaces \[[@bib18]\].

Recently, we observed that DC-SIGN showed higher levels of organization (clustering) on the surface of DCs, depending upon the differentiation state of the DCs when they developed from monocytic precursors \[[@bib19]\]. High-resolution electron microscopy images demonstrated a direct relationship between DC-SIGN function as a viral receptor and its microlocalization on the plasma membrane. During development of human monocyte-derived DCs, DC-SIGN organization changes from a random distribution pattern into well-defined microdomains on the cell membrane. These submicron-sized microdomains have an average diameter of 100--200 nm, as established by electron microscopy and near-field scanning optical microscopy \[[@bib20]\]. The organization of DC-SIGN in microdomains on the plasma membrane is important for the binding and internalization of virus particles, suggesting that these multimolecular assemblies of DC-SIGN act as a docking site for pathogens such as HIV-1 to invade the host \[[@bib19]\].

Further investigation is necessary to establish whether also other CLRs are organized in similar multi-molecular assemblies at the cell membrane.

Pathogen recognition by C-type lectins: protection or evasion?
==============================================================

There is increasing evidence to suggest that pathogens use several strategies to evade host immune surveillance \[[@bib5], [@bib6]\].

DC-SIGN was first identified as an HIV-1 receptor that enhanced infection of T lymphocytes in *trans* \[[@bib21]\]. Recently, Arrighi *et al*. \[[@bib22]\] demonstrated that DC-SIGN is required for the formation of an infectious synapse between HIV-1-bearing DCs and resting CD4^+^ T cells. More specifically, the use of small RNAi-expressing lentiviral vectors specifically to knock down DC-SIGN on DCs showed that DC-SIGN^−^ DCs are still able to internalize HIV-1, although the binding of virions was found to be reduced, but they cannot transfer HIV-1 infection to target cells \[[@bib22], [@bib23]\]. It is becoming clear that other viruses besides HIV-1 target DC-SIGN to promote their dissemination and modulate DC function for establishing chronic infections. Hepatitis C virus has recently been shown to target DC-SIGN and L-SIGN to escape lysosomal degradation \[[@bib24]\]. Similarly, severe acute respiratory syndrome coronavirus binds to DC-SIGN and is transferred by DCs to susceptible target cells through a synapse-like structure \[[@bib25]\].

In addition to viruses, *Helicobacter pylori* has also been demonstrated to target DC-SIGN to block a polarized Th1 response \[[@bib26]\]. This bacterium binds to DC-SIGN via its lipopolysaccharide (LPS), which exposes Lewis blood group antigens. In particular, reversible on--off switching of specific fucosyltransferases regulates the expression of Lewis-X and -Y on the LPS, thus causing LPS phase variation (Lewis-X^+^/Y^+^ and Lewis-X^+^/Y^−^) within a strain. Interestingly, whereas Lewis-X^+^/Y^−^ *H. pylori* escapes binding to DCs, the Lewis-X^+^/Y^+^ phase variant exploits binding to DC-SIGN to increase interleukin-10 levels and block the skewing of naïve T cells to Th1 cells \[[@bib26]\].

A similar evasion strategy has also been developed by the yeast-like fungus *Cryptococcus neoformans*, which infects the respiratory and nervous systems, to escape aggregation by SP-D \[[@bib27]\]. Only acapsular *C. neoformans* is aggregated by SP-D and subsequently removed by microciliary clearance. Therefore, after deposition in the lung, *C. neoformans* readily starts producing a capsule, thus also releasing soluble capsular components, including glucuronoxylomannan (GXM). SP-D binds with high affinity to soluble glucuronoxylomannan, and this interaction has been shown to inhibit SP-D aggregation of acapsular *C. neoformans*, thus interfering with pathogen clearance \[[@bib27]\].

*Bordetella pertussis*, the causative agent of human whooping cough, uses a slightly different mechanism for resisting the bactericidal effects of SP-A \[[@bib28]\]. SP-A binds via its CRD to the lipid A component of LPS. However, *B. pertussis* LPS has a terminal trisaccharide which apparently shields the bacteria from SP-A-mediated clearance by sterically limiting access of SP-A to the lipid A region \[[@bib28]\].

Despite these examples of immune evasion by pathogens through CLRs, we must not forget that these receptors have a fundamental role in limiting the early proliferation of infectious microorganisms. The importance of MBL in restricting the complications associated with *Staphylococcus aureus* infection is highlighted by studies involving MBL-null mice \[[@bib29]\]. This *in vivo* study demonstrated that 100% of the MBL-null mice died 48 hours after exposure to an intravenous inoculation of *S. aureus* compared with a 45% mortality rate in wild-type mice \[[@bib29]\]. Similarly, SP-D knockout mice displayed a delayed clearance of *Pneumocystis carinii* infection, increased inflammation and altered nitric oxide metabolism \[[@bib30]\].

Interestingly, although DC-SIGN is exploited by several viruses to escape lysosomal degradation, Moris *et al*. \[[@bib31]\] recently demonstrated that DC-SIGN does not always protect captured virions against degradation. In fact, a fraction of the incoming viral material is processed by the proteasome and leads to activation of anti-HIV-specific cytotoxic T lymphocytes by DC-SIGN-expressing cells \[[@bib31]\]. This work suggests that the different routing of the incoming viral material might be directly related to the viral load. Additional evidence for a protective *in vivo* role for a SIGN family member is provided by Lanoue *et al*. \[[@bib32]\]. Mice lacking SIGN-R1 are significantly more susceptible to *Streptococcus pneumoniae* infection and fail to clear the bacteria from the circulation, showing an important role for SIGN-R1 in the protection against septicemia \[[@bib32]\].

The Langerhans cell-specific C-type lectin langerin has also been shown to have a crucial role in the generation of CD1a-restricted T cell clones against a *Mycobacterium leprae* lipid antigen \[[@bib33]\].

Recent findings have demonstrated that Pneumocystis induces nuclear translocation of nuclear factor-κB in human alveolar macrophages primarily through interactions with the macrophage mannose receptor (MMR) \[[@bib34]\]. This identifies the MMR as a pattern recognition receptor (PRR) which, besides mediating phagocytosis, is also capable of signaling in response to infectious non-self challenge.

Levels of complexity in pathogen recognition
============================================

In the past few years, evidence has accumulated illustrating the important role of the C-type lectins for the normal functioning of the immune system. From this, a picture is emerging that suggests that microbial recognition is based on networks between C-type lectins and other innate immune recognition receptors.

For example, the lectin pathway of complement activation is essential in innate antimicrobial defense. This is initiated by multimolecular complexes composed of MBL and MBL-associated serine proteases, which subsequently cleave complement C4 and C2, thus triggering the complement cascade. Studies with both MBL-null mice and MBL-deficient individuals have demonstrated that the absence of MBL-mediated complement activation severely increases susceptibility to herpes simplex virus-2 infection \[[@bib35]\]. Similarly, a direct interaction of MBL with *Candida albicans* has been documented; this was shown to result in agglutination and accelerated complement activation and to lead to fungal growth inhibition, even in the absence of opsonophagocytosis by DCs \[[@bib36]\].

Interestingly, cooperation among members of the C-type lectin family has also been reported. Taylor *et al*. \[[@bib37]\] demonstrated that in murine peritoneal macrophages, SIGN-R1 exhibits additive cooperation with the β-glucan receptor dectin-1 in the nonopsonic recognition of yeast.

In addition, SP-A and SP-D, but not MBL, have been shown to enhance phagocytosis of *Mycobacterium avium* by macrophages through upregulation of MMR cell-surface expression and activity \[[@bib38]\].

Furthermore, SP-A has been reported to augment the phagocytosis of *S. pneumoniae* by alveolar macrophages through an increase in cell-surface localization of scavenger receptor A \[[@bib39]\].

These recent observations, together with previous reports documenting crosstalk between C-type lectins and TLRs \[[@bib40], [@bib41]\], clearly indicate that specific interactions among different immune receptors might differentially regulate the outcome of an immune response against a specific pathogen.

Conclusions
===========

In the recognition of pathogens, several levels of complexity can be distinguished that might determine the destiny of the pathogen and the outcome of an immune response ([Figure 1](#fig1){ref-type="fig"} ). Firstly, the pathogen itself expresses at its surface a specific PAMP, or a combination of different PAMPs, which dictates the recognition by specific receptors. Secondly, the set of PRRs expressed varies among different cells, resulting in a specific set of pathogen-recognition receptors which is different for each cell type of the immune system. Thirdly, changes in PRR cell-surface distribution adds yet another level of complexity, modulating the binding to certain carbohydrate moieties, and thus regulating the affinity for different ligands. Finally, these receptors have been shown to interact with each other, thereby giving rise to a network of multimolecular complexes that add a fourth level of complexity to pathogen recognition. Unraveling the precise mechanisms regulating the formation and exact function of these receptor networks is the present challenge.Figure 1Levels of complexity in lectin-mediated pathogen recognition determine pathogen destiny and the immune response. Differences in PAMPS expressed by pathogens and PRRs on host cells determine a first and second level of complexity in recognition. **(a)** Changes in receptor distribution at the cell surface might further influence the binding to a pathogen and the subsequent intracellular routing of the pathogen, and determine pathogen survival or lysosomal degradation. **(b)** The formation of mixed multimolecular receptor assemblies (for example, between CLRs and TLRs, complement receptors or other CLRs) might further extend the PAMP profile. Moreover, the outcome of a cell response to a pathogen (for example, in terms of the release of different cytokines) might differ depending on the triggering of single receptors or receptor complexes.
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